Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study
Conclusions:
Our study showed that losartan had the most beneficial effect on SUA level among five ARBs, and that there was no significant difference in the unfavorable effects on SUA level among four ARBs other than losartan, at least during one year. These findings provide evidence of an effect of ARBs on SUA level, and support the benefit of the use of losartan in hypertensive patients with type 2 DM.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Yayoi NishidaYasuo TakahashiNorio SusaNobukazu KanouTomohiro NakayamaSatoshi Asai Source Type: research
More News: Cardiology | Cardiovascular | Cozaar | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Diovan | Endocrinology | Heart | Laboratory Medicine | Losartan | Study